EGFR and lung cancer: We showed that inhibition of EGFR by gefitinib reduced hypoxia-induced HIF-1α expression, compatible with the previous report showing a decrease in hypoxia-induced accumulation of HIF-1α after EGFR inhibition in human lung cancer A549 cells (29).